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Abstract
Immune cells undergo changes in gene expression and metabolism when activated 
by a foreign molecule. Although the changes are short-lived in response to an 
acute infection, they persist in disorders with underlying chronic inflammation. To 
understand how changes in gene expression relate to changes in metabolism, the 
expression of metabolic transporter proteins was analyzed in response to chronic 
inflammation in a mouse monocyte cell line. Specifically, Glucose Transporter-1 
(GLUT1), Monocarboxylate Transporter-1 (MCT1), Monocarboxylate Transporter-4 
(MCT4), and Glutamate Aspartate Transporter (GLAST) were analyzed, and it was 
hypothesized that all the transporters would increase in expression in response to 
a prolonged inflammatory stimulus when compared to control conditions. RAW 
264.7 mouse monocytes were treated with lipopolysaccharide (LPS, 1 mg/mL) or 
a similar volume of phosphate buffered saline (PBS) for 24 hours. The cells were 
fixed and subjected to immunocytochemical analyses. Relative fluorescence intensity 
was measured for the different treatment groups and compared statistically. It was 
determined that expression of GLUT1 and MCT4 increased in response to LPS, 
as compared to PBS, whereas MCT1 and GLAST decreased in response to LPS, as 
compared to PBS. Although the hypothesis was not supported, the data do reflect 
those of a study using human immune cells that were derived from diabetic patients. 
The data suggest that this cell-based system could represent the conditions of 
immune cells derived from humans with chronic inflammation and therefore be used 
for studies and aimed at finding treatments for those conditions.
Introduction
Humans are exposed to millions of foreign molecules every day. While some of those 
molecules are benign, others can cause infections and diseases. To avoid infection 
and maintain good health, the human body relies on the immune system to protect 
against the foreign molecules that are pathogenic or disease-causing. 
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There are two different arms of the immune response: the adaptive and the 
innate. The adaptive immune system uses specific interactions between molecules 
and receptors on lymphocytes to initiate a response that is remembered such that a 
more robust response is generated when the foreign molecule is encountered again 
(Marshall et al., 2018). The innate immune system is the body’s first line of defense 
against invading pathogens and relies on the recognition of patterns commonly 
found in microbes and other foreign entities (Marshall et al., 2018). The innate 
immune system relies on leukocytes to engulf the foreign particles and produce small 
molecules to fight the infection (Marshall et al., 2018).
When a pathogen invades, the innate immune system elicits an inflammatory 
response. At the site of infection, a series of blood vessel defense responses facilitate 
the attachment and action of phagocytic leukocytes such as monocytes. The action 
carried out by monocytes is mediated by a cell-surface protein that detects pathogens 
and initiates an immune response. The inflammatory response is initiated by 
activation of pattern recognition receptors, or PRRs, and mediated by intracellular 
signaling molecules that cause the monocyte to become activated (Janssens and 
Bayaert, 2003). The molecule lipopolysaccharide (LPS), a component of the outer 
membrane of Gram-negative bacteria, is a known mediator of inflammation through 
activation of a PRR (Janssens and Bayaert, 2003).
Monocytes, like all cells, rely on the production of cellular energy to maintain 
their cell functions. In a non-activated state, basic cellular needs are carried out 
using cellular respiration, in which organic molecules are oxidized through a series 
of steps for the ultimate production of adenosine triphosphate (ATP; Ratter et 
al., 2018). Once that monocyte becomes activated through the stimulation of a 
cell-surface receptor by a foreign molecule, the amount of ATP required increases. 
Therefore, the cellular metabolism of the monocyte increases. Typically, ATP is 
produced through aerobic respiration. In this process, glucose is brought into the 
cell using specific transporters. It is then processed through a pathway known as 
glycolysis to generate the molecule pyruvate, which is then transformed into acetyl 
coA and enters the citric acid cycle (Li et al., 2014). Reduced high energy electron 
carriers generated during glycolysis, acetyl coA production, and the citric acid cycle 
fuel oxidative phosphorylation in mitochondria to produce large amounts of ATP. 
However, in monocytes that are chronically activated, through persistent infections, 
auto-immune disorders, and diseases like diabetes, ATP production occurs through 
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aerobic glycolysis (Sun et al., 2020). After pyruvate is generated from glucose through 
the process of glycolysis, it is reduced to lactate through the process of fermentation. 
This produces less ATP per reaction yet an increased amount overall because of the 
increased speed of performing fewer reactions (Li et al., 2014). The lactate is then 
removed from the cell using membrane-associated transporters. 
The ability to study how monocytes respond to chronic inflammation is 
critical for the future development of treatments and therapies that can minimize 
the effects of diseases including COVID-19, cancer, diabetes, heart disease, and 
neuroinflammation. Therefore, the purpose of this study was to analyze transporter 
expression in the RAW 264.7 mouse monocyte cell line to generate a cell-based assay 
system for studying chronic inflammation in monocytes. 
The expression of transporters for glucose, lactate, and amino acids in RAW 
264.7 cells subjected to chronic inflammation or control conditions was measured 
using biochemical assays. It was hypothesized that the expression of transporters for 
glucose, lactate, and amino acids would increase in response to chronic inflammation, 
when compared to the control conditions. Immunohistochemical analyses indicate 
that expression of the glucose transporter GLUT1 and the lactate transporter MCT4 
increased in response to chronic inflammation, when compared to the control. 
However, expression of the lactate transporter MCT1 and the amino acid transporter 
GLAST decreased in response to chronic inflammation when compared to the control. 
Although the results did not fully support the hypothesis, they do align with published 
reports of the metabolic gene expression profile of monocytes recovered from diabetic 
patients (Ratter et al., 2018). Overall, it appears that the cell-based system will serve as 
an appropriate model system to study chronic inflammation in monocytes.
Methods 
Cell culture
RAW 264.7 monocytes (American Type Culture Collection) were grown at 37°C in 
5% CO2 in RPMI 1640 medium (Gibco) containing 10% FBS (Hyclone). For the 
assays, the RAW 264.7 cells were plated on chamber slides (Corning) in serum-free 
RPMI 1640 medium and allowed to attach overnight.  
The cells were treated with LPS (1 μg/mL; InvivoGen) or Dulbecco’s phosphate 
buffered saline (D-PBS) for 24 hours at 37°C in 5% CO2. The cells were fixed 
for subsequent analyses by removing the cell media and incubating in 4% 
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paraformaldehyde in phosphate buffered saline (PFA) for 15 minutes at room 
temperature. 
Immunocytochemistry
For immunohistochemistry, the cells were treated with blocking buffer (tris buffered 
saline [TBS] containing 0.1% Tween 20 and 2% normal goat serum [Pierce/
Thermo Scientific]) and incubated at 4°C overnight. The cells were incubated in the 
presence of antibodies specific for MCT1 (Millipore), MCT4 (Millipore), GLUT1 
(Millipore), or GLAST (Millipore), diluted to 1 μg/mL in blocking solution for 
one hour at 37°C and then at 4°C overnight. After washing with at least 10 changes 
of TBS, the cells were treated with Alexa488-conjugated goat anti-rabbit (GAR) 
secondary antibody, diluted 1:250 in blocking solution, for 30 minutes at 37°C. The 
cells were washed 10 times with TBS, with the first wash containing 4’,6-diamidino-
2-phenylindole (DAPI; Thermo Fisher Scientific) diluted to 1:1000. Cover slips 
were mounted with 30% glycerol containing p-phenylenediamine (Sigma Chemical 
Company) and the cells were visualized and imaged on an Olympus FV1000 
microscope. Subsequently, fluorescence was quantified using the accompanying 
software and specifying regions of interest (ROIs). Expression in LPS-treated 
cells versus D-PBS-treated cells was compared using a paired, one-tailed T test. 
Significance was measured at p < 0.05.
Results
The use of cell lines to test cellular responses to various stimuli is an important first 
step in designing treatments for human disorders. The RAW 264.7 cell line is a 
mouse monocyte primary cell line that may serve as a useful system for studying the 
cellular effects of chronic inflammation, like that observed in patients with auto-
immune disorders and diabetes. Therefore, the purpose of the present study was to 
analyze the expression of nutrient transporters in RAW 264.7 cells in response to 
stimuli that mimic chronic inflammatory conditions compared to saline control.
The expression of transporters used to move monocarboxylates like pyruvate, 
lactate, and ketone bodies across the plasma membrane was compared in chronically 
inflamed monocytes and control cells. It was determined that expression of 
Monocarboxylate Transporter-1 (MCT1) was significantly decreased in response to 24 
hours of incubation with lipopolysaccharide (LPS), a known inducer of inflammation 
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in monocytes, when compared to saline control (Figure 1). Conversely, expression of 
a related transporter, MCT4, significantly increased in expression in response to 24 
hours of incubation with LPS, when compared to control conditions (Figure 2).
The expression of a transporter used to move the monosaccharide glucose across 
the plasma membrane was compared in chronically inflamed monocytes and control 
cells. Expression of the transporter Glucose Transporter-1 (GLUT1) significantly 
increased in expression in response to 24 hours of exposure to LPS, when compared 
to treatment with saline (Figure 3).
The expression of a transporter used to move the amino acids across the plasma 
membrane was compared in chronic inflammatory versus control conditions. 
Expression of the Glutamate Aspartate Transporter (GLAST) was determined to 
decrease in response to LPS, when compared to control conditions (Figure 4).
Discussion
The purpose of this investigation was to analyze transporter expression in the RAW 
264.7 mouse monocyte cell line to generate a cell-based assay system for studying 
chronic inflammation in monocytes. Glucose, lactate, and amino acid transporters 
were tested using immunohistochemical assays. It was hypothesized that each of 
the transporters analyzed would have increased expression in response to a chronic 
inflammatory stimulus because of the increased need for cellular metabolism under 
those conditions. Results from immunohistochemical assays showed that this 
hypothesis was not fully supported. Expression of the glucose transporter GLUT1 
and the lactate transporter MCT4 increased under chronic conditions compared 
to control conditions, whereas expression of the lactate transporter MCT1 and 
the amino acid transporter GLAST decreased in response to chronic conditions 
compared to control conditions. The data suggest that transporters respond to an 
increased need for glucose and for removal of lactate from the cells, via MCT4, and 
that the cell decreases metabolism related to amino acids.  
It is well established that the immune cells reprogram their metabolism in 
response to an inflammatory stimulus. Cells of the innate and adaptive arms of the 
immune system, which typically produce ATP via aerobic respiration or oxidative 
phosphorylation, switch to the production of ATP via aerobic glycolysis for a rapid 
host defense mechanism (Sun et al., 2020). Like the observation in the present study, 
the cells increase the expression of GLUT1 to increase delivery of glucose to the cells. 
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The mechanism of aerobic glycolysis produces lactate, which results in the increased 
expression of MCT4, to ensure that the lactate is removed from the cell so that 
glycolysis can continue. That reprogramming reverts to the homeostatic mechanism 
after the inflammatory insult has been removed from the system. However, in cases 
of chronic inflammation, the pendulum swings toward glycolysis, with the immune 
cells remaining in that heightened state of activation (Sun et al., 2020).
A recent study of peripheral blood mononuclear cells (PBMCs), which include 
monocytes, isolated from diabetic and healthy patients found that transporter 
expression changed in response to chronic inflammation resulting from diabetes. 
Microarray analyses of RNA isolated from diabetic and healthy PBMCs indicated 
that expression of MCT4 is increased, whereas expression of MCT1 is not affected 
(Ratter et al., 2018). Increased extracellular lactate concentrations were observed 
to decrease the production of pro-inflammatory cytokines in PBMCs from healthy 
individuals, which suggests a feedback mechanism for regulation of the immune 
response in acutely activated monocytes (Ratter et al., 2018). Unfortunately, the 
study did not determine the effects of increased extracellular lactate on chronically 
activated PBMCs (Ratter et al., 2018).
The observations from the present study align with known metabolic changes in 
activated immune cells. The metabolic transporter expression patterns suggested that 
a switch from oxidative phosphorylation to aerobic glycolysis occurred, like that seen 
for chronically activated monocytes and PBMCs of diabetic patients. This suggests 
that the RAW 264.7 cells challenged with LPS for 24 hours represent the conditions 
observed in chronically inflamed humans and can therefore be used as a cell-based 
model for studying diseases including COVID-19, cancer, diabetes, heart disease, 
and neuroinflammation.
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Figures
Figure 1. Expression of Monocarboxylate Transporter-1 (MCT1) in response to 
chronic inflammation. The white bars represent the average relative fluorescence 
of regions of interest (ROI) in RAW 264.7 cells in response to phosphate buffered 
saline (PBS) treatment for 24 hours. The gray bars represent the average relative 
fluorescence of ROI in RAW 264.7 cells in response to lipopolysaccharide (LPS) 
treatment for 24 hours. The error bars represent the standard error. * = p<0.05 via a 
paired, one-tailed T-test.
Figure 2. Expression of Monocarboxylate Transporter-4 (MCT4) in response to 
chronic inflammation. The white bars represent the average relative fluorescence 
of regions of interest (ROI) in RAW 264.7 cells in response to phosphate buffered 
saline (PBS) treatment for 24 hours. The gray bars represent the average relative 
fluorescence of ROI in RAW 264.7 cells in response to lipopolysaccharide (LPS) 
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Figure 3. Expression of Glucose Transporter-1 (GLUT1) in response to chronic 
inflammation. The white bars represent the average relative fluorescence of regions 
of interest (ROI) in RAW 264.7 cells in response to phosphate buffered saline (PBS) 
treatment for 24 hours. The gray bars represent the average relative fluorescence of ROI 
in RAW 264.7 cells in response to lipopolysaccharide (LPS) treatment for 24 hours. 
The error bars represent the standard error. * = p<0.05 via a paired, one-tailed T-test.
Figure 4. Expression of Glutamate Aspartate Transporter (GLAST) in response 
to chronic inflammation. The white bars represent the average relative fluorescence 
of regions of interest (ROI) in RAW 264.7 cells in response to phosphate buffered 
saline (PBS) treatment for 24 hours. The gray bars represent the average relative 
fluorescence of ROI in RAW 264.7 cells in response to lipopolysaccharide (LPS) 
treatment for 24 hours. The error bars represent the standard error. * = p<0.05 via a 
paired, one-tailed T-test.
Figure 4.
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